We are excited to attend the Pharma Contract Manufacturing Conference this April 13th–14th at the Eurostars Sitges in Barcelona, Spain!
As we continue to expand our global expertise into local impact, we are eager to connect with industry leaders and stay at the forefront of CMO market trends and technologies. With mRNA capabilities and 3 EU-approved, state-of-the-art facilities, EVA Pharma is dedicated to bringing the latest manufacturing innovations to our partners.
Let’s connect in Barcelona to discuss how we can shape the future of healthcare access together.

thumbnail_EVAxPVQ12026_website-trial1600x1200 (1).png

EVAxPVQ12026_website-trial1600x1200 (1).png

Contract manufacturing PharmaVenue althcare company operating across 70+ 

Pharma Venue

About EVA Pharma 
EVA Pharma is dedicated to improving access to affordable, high-quality medicines around the world, focusing on three core pillars: innovation, development and sustainable access. The company leverages cutting-edge technology at two research centers bringing first-of-its-kind capabilities to the Middle East and Africa including mRNA research and development from AI prediction to biological products. &nbsp;
With a 5,000-strong team of professionals, EVA Pharma produces more than one million healthcare products a day at four state-of-the-art manufacturing facilities, which are internationally recognized for innovation, and have been approved by multiple regulatory agencies. &nbsp;
 Guided by a relentless drive to ensure sustainable access to pressing yet unmet disease areas, the company’s product portfolio focuses on twelve therapeutic areas: Anti-infectives, metabolic health, bone, neuroscience, oncology, respiratory, gynecology, urology and andrology, pediatrics, ophthalmology, gastrointestinal tract, family medicine to meet both local and international demand. &nbsp;
EVA Pharma is one of the fastest-growing healthcare companies in the Middle East and Africa, with an extensive pan-African presence, while operating in more than 60 countries worldwide. &nbsp;

thumbnail_EVAxPCMQ12026_website-trial1600x1200 (1).png

EVAxPCMQ12026_website-trial1600x1200 (1).png

CPHI Worldwide 2025 Frankfurt EVA Pharma is a global healthcare company operating across 70+ countries, dedicated

Pharma Contract Manufacturing

thumbnail_hero-section-ss.jpg

hero-section-ss.jpg

CPHI Worldwide 2025

thumbnail_EVAxMIS_Ann-01-web-eng (1).png

EVAxMIS_Ann-01-web-eng (1).png

KSA Saudi Made localization Saudization Empowering health 
research and development

Saudi Made 2025

Happening at EVA Pharma

EVA Pharma’s roots stretch back over a hundred years.

Our History

Our experienced leadership team keeps us on track.

Meet our Leaders

EVA Pharma’s success is based on its dynamic team, Our people are our power.

Life at EVA Pharma

We are excited to attend the Pharma Contract Manufacturing Conference this March 23th–25th at the Mercure Hotel MOA in Berlin!As we continue to expand our global expertise into local impact, we are eager to connect with industry leaders and stay at the forefront of CMO market trends and technologies. From mRNA capabilities to our high-capacity in our 3 EU approved state of the art facilities, EVA Pharma is dedicated to bringing the latest manufacturing innovations to our partners.Let’s connect in Berlin to discuss how we can shape the future of healthcare access together.

thumbnail_Screenshot 2025-10-07 123536.png

Screenshot 2025-10-07 123536.png

EVA Company Profile - 2025.pdf

Company Profile

thumbnail_CPHI25_webthum_SCMO.png

CPHI25_webthum_SCMO.png

Contract Manufacturing 2025-2026.pdf

Contract Manufacturing

Event

EVA Pharma is participating in&nbsp;WHX Dubai (formerly Arab Health), one of the region’s leading healthcare exhibitions, to share what EVA Pharma has achieved and to discuss what lies ahead for the future of the pharmaceutical field.
Let’s shape the future of healthcare together by meeting our team:
February 9-12
Stand 31.A56

thumbnail_cjkhdscj (1).png

cjkhdscj (1).png

EVA Pharma is participating in WHX Dubai

EVA Pharma is participating in&nbsp;WHX Dubai (formerly Arab Health), one of the region’s leading healthcare exhibitions, to share what EVA Pharma has achieved and to discuss what lies ahead for the future of the pharmaceutical field.
Let’s shape the future of healthcare together by meeting our team:
February 9-12
Stand 31.A56

EVA Pharma is participating in WHX Dubai!

EVA Pharma is participating in WHX Dubai (formerly Arab Health), one of the region’s leading healthcare exhibitions, to share what 

WHX Dubai

Curious about where mRNA is going? Join EVA Pharma's R&amp;D scientists at APRL Shanghai sharing what it’s really like to build next-generation mRNA vaccines and therapeutics—hands-on, day by day—at the heart of our mRNA innovation hub.
&nbsp;
We’re opening up the conversation on how these capabilities are taking shape, building on the collaborations we kicked off last year with Quantoom Biosciences and DNA Script, and what it truly means to localize mRNA technologies for Africa and the Middle East.
If you’re around, join our roundtable and keynote to hear directly from the scientists driving the work.

thumbnail_Asia-Pharma-R&D-Leaders-web 1.png

Asia-Pharma-R&D-Leaders-web 1.png

2026 APRL - The 14th Asia Pharma R&D Leaders

Curious about where mRNA is going? Join EVA Pharma's R&amp;D scientists at APRL Shanghai sharing what it’s really like to build next-generation mRNA vaccines and therapeutics—hands-on, day by day—at the heart of our mRNA innovation hub.&nbsp;
We’re opening up the conversation on how these capabilities are taking shape, building on the collaborations we kicked off last year with Quantoom Biosciences and DNA Script, and what it truly means to localize mRNA technologies for Africa and the Middle East.
If you’re around, join our roundtable and keynote to hear directly from the scientists driving the work.

News and Media

Curious about where mRNA is going? Join EVA Pharma's R&D scientists at APRL Shanghai
 


EVA Pharma is dedicated to improving access to affordable, high-quality medicines around the world, focusing on three core pillars: innovation, development and sustainable access. The company leverages cutting-edge technology at two research centers bringing first-of-its-kind capabilities to the Middle East and Africa including mRNA research and development from AI prediction to biological products. &nbsp;
With a 5,000-strong team of professionals, EVA Pharma produces more than one million healthcare products a day at four state-of-the-art manufacturing facilities, which are internationally recognized for innovation, and have been approved by multiple regulatory agencies. &nbsp;
 Guided by a relentless drive to ensure sustainable access to pressing yet unmet disease areas, the company’s product portfolio focuses on twelve therapeutic areas: Anti-infectives, metabolic health, bone, neuroscience, oncology, respiratory, gynecology, urology and andrology, pediatrics, ophthalmology, gastrointestinal tract, family medicine to meet both local and international demand. &nbsp;
EVA Pharma is one of the fastest-growing healthcare companies in the Middle East and Africa, with an extensive pan-African presence, while operating in more than 60 countries worldwide. &nbsp;

Company Profile - Global

thumbnail_Screenshot 2025-12-11 150609.png

Screenshot 2025-12-11 150609.png

EVA Company Profile - saudimade SA 2025 Q4-web-Digital.pdf

Company Profile - Saudi Arabia 

thumbnail_Screenshot 2025-06-17 113128.png

Screenshot 2025-06-17 113128.png

EVA Pharma Product Portfolio 2025 Q3.pdf

Product Portfolio

thumbnail_Screenshot 2025-06-17 111006.png

Screenshot 2025-06-17 111006.png

Limitless Narturals Interactive Brochure 2025.pdf

Limitless Naturals Portfolio

thumbnail_Screenshot 2025-06-17 112622.png

Screenshot 2025-06-17 112622.png

MARC CPHI 2025 digital.pdf

Clinical Research

thumbnail_CPHI25_webthum_Animal-Health-Portfolio.png

CPHI25_webthum_Animal-Health-Portfolio.png

Portfolio Animal health  09 1.pdf

Animal Health Portfolio

thumbnail_Screenshot 2025-10-16 161715.png

Screenshot 2025-10-16 161715.png

EU-Product Portfolio 2025 -2026.pdf

EU- Product Portfolio

EVA Pharma &nbsp;is dedicated to improving access to affordable, high-quality medicines around the world, focusing on three core pillars: innovation, development and sustainable access. The company leverages cutting-edge technology at two research centers bringing first-of-its-kind capabilities to the Middle East and Africa including mRNA research and development from AI prediction to biological products. &nbsp;
With a 5,000-strong team of professionals, EVA Pharma produces more than one million healthcare products a day at four state-of-the-art manufacturing facilities, which are internationally recognized for innovation, and have been approved by multiple regulatory agencies. &nbsp;
 Guided by a relentless drive to ensure sustainable access to pressing yet unmet disease areas, the company’s product portfolio focuses on twelve therapeutic areas: Anti-infectives, metabolic health, bone, neuroscience, oncology, respiratory, gynecology, urology and andrology, pediatrics, ophthalmology, gastrointestinal tract, family medicine to meet both local and international demand. &nbsp;
EVA Pharma is one of the fastest-growing healthcare companies in the Middle East and Africa, with an extensive pan-African presence, while operating in more than 60 countries worldwide. &nbsp;

thumbnail_about-section.png

about-section.png

large_pexels-kaboompics-com-6335@2x.png

medium_pexels-kaboompics-com-6335@2x.png

small_pexels-kaboompics-com-6335@2x.png

thumbnail_pexels-kaboompics-com-6335@2x.png

pexels-kaboompics-com-6335@2x.png

Are you a Journalist or Media Representative and need information about us? Please feel free to get in touch with our PR Team

Are you a Healthcare professional?

Happening at EVA

13

Event

Pharma Venue

13

Event

23

Event

28

Event

15

Event

Media Contact

Find out more about EVA Pharma

EVA Pharma’s roots stretch back over a hundred years.

Our experienced leadership team keeps us on track.

EVA Pharma’s success is based on its dynamic team, Our people are our power.